QTTB
Q32 Bio Inc.
NASDAQ · USHealthcareBiotechnology
$15.04-0.07%
Price as of Jul 20, 2026
QTTB capital
Q32 Bio Inc. capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- 0.29x
- Net debt / equity
- -0.80x
- Debt / assets
- 0.21x
- Debt / EBITDA
- 0.62x
- Net debt / EBITDA
- -1.68x
Liquidity & coverage
- Current ratio
- 5.36x
- Quick ratio
- 5.36x
- Cash ratio
- 4.76x
- Interest coverage
- 21.41x
- EBITDA / interest
- 22.15x
- Working capital
- $46.5M
Cash & dividend
- FCF / debt
- -2.01x
- Cash flow / debt
- -2.01x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.